Abilify
Ailment: Depression
U.S. Sales: $3.8 billion
Owner: Otsuka Holdings
Originally designed to treat schizophrenia, the biggest selling antipsychotic medication in the world is now prescribed for a range of mental disorders.
In May, a federal judge ruled against Otsuka Holdings in the company’s attempt to thwart a rival generic drug from coming to market.
